Story

MannKind Joins Hunt for EpiPen Replacement

BIOTECH: Price controversy could open market for year-old research project.

Amid fervor over spike in cost of insulin-based EpiPen, MannKind attracts shareholder attention for its own insulin inhaler.

Story

The Valley’s Start: When Guns Boomed

Op-Ed: Watershed year of 1914.

Story

Caruso Changes Name

Caruso Affiliated, the development company behind the shopping centers Americana at Brand in Glendale and Commons at Calabasas, has changed its name to simply Caruso.

Story

Knees Are Not Meant For Knocking

USC starts clinical trial to study stem cell treatment on joints.

Innovation: A stem cell study in the Antelope Valley could lead to new therapies for knee pain.

Story

Investors Easily Swallow Amgen Drug Charges

Biotech: Shares of firm barely fall despite criminal penalty related to Aranesp.

BIOTECH: Amgen pays $762 million fine for illegally marketing an anemia drug.

Story

One Drop Puts MannKind Above $1 Threshold

PHARMA: Amazon-based marketing deal boosts company’s share price.

MannKind sees stock soar with marketing deal on Amazon Prime.

Story

North American Scientific Receives Device Clearance

North American Scientific announced that it has received the approval of the Food and Drug Administration for a low-dose radiation version of a device used to treat breast cancer.

Story

Virus Shrinks Melanoma Cells in Amgen Trial

Shares of Amgen Inc. gained more ground Thursday, two days after the company announced positive late-stage trials for a breakthrough melanoma treatment.

Story

Local Doctor Stops Cancer in Canine

A Los Angeles-based biotechnology company led by a primary care physician who runs a clinic in the San Fernando Valley announced Monday that its investigational drug has eliminated all signs of cancer in a pet dog.

Tease photo
Story

Valley Hospital Staff Receive COVID Vaccine

Hospitals in the Valley region have started administering the COVID-19 vaccine made by Pfizer Inc.

Story

Amgen Settles Claims for $71 Million

The Thousand Oaks company was alleged to have violated consumer protection laws in 48 states and the District of Columbia.

Story

Valencia Hospital Fined for Noncompliance

The California Department of Public fined Health Henry Mayo Newhall Memorial Hospital in Valencia for its failure to implement safe practices in the administration of medication.

Story

Does Getting Tipsy Make You Artsy?

Pinot’s Palette is latest franchise in the ‘paint-and-sip’ craze.

Entertainment: At Pinot’s Palette, you can sip wine and create art with friends.

Tease photo
Story

AROUND THE VALLEYS

AROUND THE VALLEYS

Story

Kythera Reports Higher-Than-Expected Loss

Kythera Pharmaceuticals Inc. announced a higher-than-expected loss in the fourth quarter, which it attributed to the costs of late-stage clinical trials of its primary pipeline product, an injected drug to reduce chin fat.

Story

Amgen's Arthritis Drug Avsola Gets FDA Approval

Amgen Inc. on Friday announced its biosimilar treatment for rheumatoid arthritis was approved by the Food and Drug Administration.

Story

Update: FDA Panel Recommends Afrezza Approval

Shares of MannKind Corp. more than doubled in after-hours trading on Tuesday after an FDA advisory panel recommended the agency approve the Valencia company's Afrezza insulin inhaler.

Story

Spike in Food Prices Eats Up Profits for Restaurant Chains

CORPORATE FOCUS: The jury is still out on the question of whether high-protein diets will slim you down, but one thing for sure is getting thinner restaurant profit margins.

Story

Amgen Income Drops in Q1

Lower demand for its anemia drugs contributed to Amgen Inc. reporting a drop in its net income in the first quarter when compared to a year ago.

Story

Legislature Passes Bill Protecting Radiation Patients

The State Legislature gave final approval to a bill requiring stricter standards for hospitals in order to prevent radiation overdoses of patients.